← Return to Clinical Trials: they are not designed only to be a “last resort”

Discussion

Clinical Trials: they are not designed only to be a “last resort”

Pancreatic Cancer | Last Active: Sep 13 7:47am | Replies (42)
Comment receiving replies
@gamaryanne

@aristidina
Yes, I am on the doublet trial of RMC 9805 and RMC 6236.

These target KRAS mutations.

@markymarkfl -was your a BRCA trial? Wishing you the best on your search for next steps

Jump to this post

Replies to "@aristidina Yes, I am on the doublet trial of RMC 9805 and RMC 6236. These target..."
marienewland | @mnewland99 | Aug 7 7:52am

gamaryanne: I had some communications with Markymarkfl back in June and it was Trop2 protein at HD Anderson in Houston; stem cell approach. I know he also has ATM and KRAS12D mutations as I do and CHEK (which I don’t).
I’m also wondering if you will need to go through a phase 3 trial that might include a placebo?

VIEW AND REPLY